https://syn-117inhibitor.com/p....recision-regarding-c
The primary outcome measure was overall survival, denoted as OS. Secondary objectives were to measure progression-free survival (PFS), safety, and quality of life (QoL). Based on prognostic criteria (GPC/PPC), patients were classified into two subgroups: one with a good prognosis (fewer than three metastatic sites at inclusion, 18 months from first metastasis diagnosis to inclusion) and the other with a poo
Like
Comment
Share
